These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31881489)

  • 1. Novel pleconaril derivatives: Influence of substituents in the isoxazole and phenyl rings on the antiviral activity against enteroviruses.
    Egorova A; Kazakova E; Jahn B; Ekins S; Makarov V; Schmidtke M
    Eur J Med Chem; 2020 Feb; 188():112007. PubMed ID: 31881489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3.
    Schmidtke M; Wutzler P; Zieger R; Riabova OB; Makarov VA
    Antiviral Res; 2009 Jan; 81(1):56-63. PubMed ID: 18840470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of the anti-enterovirus activity of a series of pleconaril/pirodavir-like compounds.
    Bernard A; Lacroix C; Cabiddu MG; Neyts J; Leyssen P; Pompei R
    Antivir Chem Chemother; 2015 Apr; 24(2):56-61. PubMed ID: 26071135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of pleconaril against enteroviruses.
    Pevear DC; Tull TM; Seipel ME; Groarke JM
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2109-15. PubMed ID: 10471549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment.
    Schmidtke M; Hammerschmidt E; Schüler S; Zell R; Birch-Hirschfeld E; Makarov VA; Riabova OB; Wutzler P
    J Antimicrob Chemother; 2005 Oct; 56(4):648-56. PubMed ID: 16150864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrazolopyrimidines: Potent Inhibitors Targeting the Capsid of Rhino- and Enteroviruses.
    Makarov VA; Braun H; Richter M; Riabova OB; Kirchmair J; Kazakova ES; Seidel N; Wutzler P; Schmidtke M
    ChemMedChem; 2015 Oct; 10(10):1629-34. PubMed ID: 26260222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses.
    Egorova A; Ekins S; Schmidtke M; Makarov V
    Eur J Med Chem; 2019 Sep; 178():606-622. PubMed ID: 31226653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site.
    Wald J; Pasin M; Richter M; Walther C; Mathai N; Kirchmair J; Makarov VA; Goessweiner-Mohr N; Marlovits TC; Zanella I; Real-Hohn A; Verdaguer N; Blaas D; Schmidtke M
    Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19109-19115. PubMed ID: 31462495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-enteroviral triple combination of viral replication inhibitors: activity against coxsackievirus B1 neuroinfection in mice.
    Stoyanova A; Nikolova I; Pürstinger G; Dobrikov G; Dimitrov V; Philipov S; Galabov AS
    Antivir Chem Chemother; 2015 Dec; 24(5-6):136-147. PubMed ID: 27815331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuated virulence of pleconaril-resistant coxsackievirus B3 variants.
    Groarke JM; Pevear DC
    J Infect Dis; 1999 Jun; 179(6):1538-41. PubMed ID: 10228078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Evolution of Pleconaril: Modified
    Volobueva A; Egorova A; Galochkina A; Ekins S; Zarubaev V; Makarov V
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32188089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleconaril: a novel antipicornaviral drug.
    Romero JR
    Expert Opin Investig Drugs; 2001 Feb; 10(2):369-79. PubMed ID: 11178348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated cell-based luminescence assay for profiling antiviral compound activity against enteroviruses.
    Zhang M; Zhang Y; Wang Y; Lv W; Zhang Y
    Sci Rep; 2019 Apr; 9(1):6023. PubMed ID: 30988314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleconaril revisited: clinical course of chronic enteroviral meningoencephalitis after treatment correlates with in vitro susceptibility.
    Wildenbeest JG; van den Broek PJ; Benschop KS; Koen G; Wierenga PC; Vossen AC; Kuijpers TW; Wolthers KC
    Antivir Ther; 2012; 17(3):459-66. PubMed ID: 22293148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 9-Arylpurines as a novel class of enterovirus inhibitors.
    Aguado L; Thibaut HJ; Priego EM; Jimeno ML; Camarasa MJ; Neyts J; Pérez-Pérez MJ
    J Med Chem; 2010 Jan; 53(1):316-24. PubMed ID: 19924996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of pleconaril, rupintrivir, and remdesivir efficiently inhibits enterovirus infections in vitro, delaying the development of drug-resistant virus variants.
    Ianevski A; Frøysa IT; Lysvand H; Calitz C; Smura T; Schjelderup Nilsen HJ; Høyer E; Afset JE; Sridhar A; Wolthers KC; Zusinaite E; Tenson T; Kurg R; Oksenych V; Galabov AS; Stoyanova A; Bjørås M; Kainov DE
    Antiviral Res; 2024 Apr; 224():105842. PubMed ID: 38417531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism of a specific capsid binder resistance caused by mutations outside the binding pocket.
    Braun H; Kirchmair J; Williamson MJ; Makarov VA; Riabova OB; Glen RC; Sauerbrei A; Schmidtke M
    Antiviral Res; 2015 Nov; 123():138-45. PubMed ID: 26391975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antiviral activity of a novel class of (5-oxazolyl)phenyl amines.
    Zhong ZJ; Zhang DJ; Peng ZG; Li YH; Shan GZ; Zuo LM; Wu LT; Li SY; Gao RM; Li ZR
    Eur J Med Chem; 2013 Nov; 69():32-43. PubMed ID: 23999140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SAR evolution and discovery of benzenesulfonyl matrinanes as a novel class of potential coxsakievirus inhibitors.
    Tang S; Li YH; Cheng XY; Li YH; Wang HQ; Kong LY; Zhang X; Jiang JD; Song DQ
    Future Med Chem; 2016 Apr; 8(5):495-508. PubMed ID: 26867658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds.
    Zhang Y; Simpson AA; Ledford RM; Bator CM; Chakravarty S; Skochko GA; Demenczuk TM; Watanyar A; Pevear DC; Rossmann MG
    J Virol; 2004 Oct; 78(20):11061-9. PubMed ID: 15452226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.